Choosing the optimal dose of human menopausal gonadotropins for ovarian stimulation in ICSI cycles
Objective: To identify the most important predictive variables for ovarian response and establishing a model that could predict the most suitable starting gonadotropin (Gn) dose to optimize ovarian stimulation thus avoiding the undesirable side effects of ovarian hyperstimulation and minimizing canc...
Main Authors: | Nawara M. Hashish, Eman K. Shaeer |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2014-06-01
|
Series: | Middle East Fertility Society Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1110569013000885 |
Similar Items
-
Mild ovarian stimulation with letrozole plus fixed dose human menopausal gonadotropin prior to IVF/ICSI for infertile non-obese women with polycystic ovarian syndrome being pre-treated with metformin: a pilot study
by: Giuseppe D’Amato, et al.
Published: (2018-09-01) -
Individualization of the FSH starting dose in IVF/ICSI cycles using the antral follicle count
by: La Marca Antonio, et al.
Published: (2013-02-01) -
The Relationship Between Serum Delta FSH Level and Ovarian Response in IVF/ICSI Cycles
by: Linli Hu, et al.
Published: (2020-11-01) -
PIVET rFSH dosing algorithms for individualized controlled ovarian stimulation enables optimized pregnancy productivity rates and avoidance of ovarian hyperstimulation syndrome
by: Yovich JL, et al.
Published: (2016-08-01) -
Effects of human chorionic gonadotropin combined with clomiphene on Serum E2, FSH, LH and PRL levels in patients with polycystic ovarian syndrome
by: Huang Yonggang, et al.
Published: (2017-02-01)